Coverage on the latest news on Hemp Inc (HEMP) a penny stock company.
Probability software for Penny stocks: http://hotstocked.com/hotstockedprecision-free3/v21 [...]
By Justin Gardner
Congress is patting itself on the back after passing the Comprehensive Addiction & Recovery Act (CARA) and sending it to Obama’s desk. The “overwhelmingly bipartisan” bill is meant to address the opioid epidemic currently gripping the U.S.
It was an easy one for congressmen to brag about to their constituency, but the legislation is notable for its failure perhaps more so than its achievement. Namely, the failure to recognize medical cannabis as part of a viable alternative for treating chronic pain, and failure to call out the role of Big Pharma in getting the nation hooked on opioids.
CARA can be applauded for seeking to direct addicts into recovery programs instead of jails, give addiction treatment to those already locked up in the drug war, and expand access of naloxone to first responders for opioid overdoses.
The problem of American opioid addiction is underscored by the fact that the U.S. has 5 percent of the world’s population but consumes 80 percent of the world’s opioids. In Tennessee, painkiller overdoses kill more people than car accidents or guns.
Nationwide, according to the CDC:
Overdose deaths involving prescription opioids have quadrupled since 1999, and so have sales of these prescription drugs. From 1999 to 2014, more than 165,000 people have died in the U.S. from overdoses related to prescription opioids.
Opioid addiction takes its biggest toll on poorer communities, with the help of sham “pain clinics” that are nothing more than pill pushers with doctorate degrees. They distribute this legal, highly addictive and deadly drug for pharmaceutical companies who make billions from wide-scale addiction.
In fact, U.S. doctors prescribe opioids at twice the rate of any other country, or 82.5 opioid prescriptions for every 100 persons in the country.
When addicts can’t afford their expensive pills anymore, they turn to the illegal form of opioids like heroin, where they are subject to the further risks of the black market created by a senseless war on drugs.
Granted, people are the problem, too. Many would rather just take a pill for their pain instead of engaging in alternative programs that require more effort. Doctors gladly fill their requests, perhaps just coming from a lunch paid for by a pharma rep.
Of course, let’s not forget Big Pharma’s partner in crime—the Food and Drug Administration (FDA). For decades, this relationship has been cultivated, building one of the biggest revolving doors in Washington, rivaling the military-industrial complex.
The FDA is instrumental in sustaining the pill-popping habits of Americans, glad to approve the manufactured products of their buddies in the industry while helping to subdue the potential of natural remedies.
The bias in the FDA is actually pretty obvious.
The day after the Food and Drug Administration (FDA) announced a new effort to limit the prescription of painkillers by doctors, the agency ignore [...]
Featured guests: NoCo Hemp Expo founder Morris Beegle and Cannabist national policy and business reporter Alicia Wallace. LOTS TO TALK ABOUT • The definitive guide on which states will be voting on medical or recreational marijuana legalization in November. • Pot shop design trends: The industry is spending millions on… [...]
BY PAUL FASSA
Andrew Katelaris dr cannabisHis actual name is Andrew Katelaris, and he was trained as an MD in Austrialia. But he was “deregistered” from mainstream medical practice because of his incessant inquiry into the medical properties of cannabis. Now he provides quality CBD to families with brain damaged children who are overwhelmed by seizures.
And he has been doing this for over 20 years despite medical cannabis is not being allowed at all in Australia. Andrew asserts, “This is a pharmaco-fascist state we live in… It’s child abuse what’s going on, I mean, what civilized country refuses to treat children with one of the safest medicines known to man?” And, “When the law is unjust, resistance is mandatory”.
Andrew also explains, “I’ve had to charge into the unknown with drug interactions, but we’ve had no adverse reactions yet, and not one family that has gone on cannabis with us has asked to come off it, although it doesn’t work for everyone. It’s a fascinatingly complex plant, we’re only just beginning to scratch around the surface in terms of its medical possibilities.” [emphasis added]
We are fortunate several individual states, around half at last count, have ignored our national government’s schedule I classification of marijuana, which labels it as having no medical merit, dangerous, and addictive. Meanwhile other more dangerous pharmaceutical drugs are scheduled with less restrictions that the legal pharmaceutical drug pushers can administer or prescribe.
But will Congress decide to move cannabis into a less restrictive category after meetings in June of 2016? Rumor has it as of this writing that they met and it hasn’t happened. This mid-east nation, often justifiably criticized for it’s extremely militant apartheid, has led the way with medical cannabis applications.
Two USA states, Washington and Colorado, have opened the doors wide open to allow cannabis for any reason. That’s the way it should be everywhere. Even used “recreationally”, it has medical merits. As a treatment for any type of mental or emotional disorder, it’s safer and more effective than anything Big Pharma pushes.
That’s part of the problem, part of the reason Big Pharma’s vaccination campaign is being enforced by laws. Eventually, that’s all they’ll have left as cannabis replaces so called modern medicine with its wide variety of applications.
The tipping point of medical cannabis legalization has been reached. The last round of medical fascism resistance will be with vaccines.
Paul Fassa is a contributing staff writer for REALfarmacy.com. His pet peeves are the Medical Mafia’s control over health and the food industry and government regulatory agencies’ corruption. Paul’s contributions to the health movement and global paradigm shift are well received by truth seekers. Visit his blog by following this link and follow him on Twitter [...]
A curious thing is happening as the war on weed crumbles before knowledge and reason. The propaganda campaign orchestrated during the 20th century by the State and its corporate allies is unraveling, exposing the absurdity of prohibition.
Since the gates have been pried open–to an extent–for medical cannabis research, we are discovering amazing benefits of this plant for a variety of ailments. Yet it is still classified by federal government as a Schedule 1 drug with “no medicinal value and high potential for addiction.”
Meanwhile, alcohol and cigarettes—other psychoactive drugs that actually do kill people—have no medicinal value and are highly addictive, yet are not subject to Controlled Substances classification.
Now, one more false tenet of Reefer Madness believers is being dispelled.
A major study from Washington University School of Medicine, to be published in June, found that teen use of cannabis has significantly decreased as states legalize cannabis.
A survey of more than 216,000 adolescents from all 50 states indicates the number of teens with marijuana-related problems is declining. Similarly, the rates of marijuana use by young people are falling despite the fact more U.S. states are legalizing or decriminalizing marijuana use and the number of adults using the drug has increased.
Researchers examined 12 years of data from the National Survey on Drug Use and Health. Instances of cannabis use fell by 10 percent, while “the number of adolescents who had problems related to marijuana — such as becoming dependent on the drug or having trouble in school and in relationships — declined by 24 percent…”
This raised an important point. While responsible adult cannabis use is far less harmful than “legal drug” use, the abuse of any drug—including cannabis—is detrimental to one’s health, especially on the developing adolescent brain. Cannabis has legitimate therapeutic benefits, but like any drug can exacerbate problems that kids have in dealing with school or troubling facets of their life.
“We were surprised to see substantial declines in marijuana use and abuse,” said study author Richard A. Grucza. “We don’t know how legalization is affecting young marijuana users, but it could be that many kids with behavioral problems are more likely to get treatment earlier in childhood, making them less likely to turn to pot during adolescence. But whatever is happening with these behavioral issues, it seems to be outweighing any effects of marijuana decriminalization.”
While this study cannot show a causal connection between the decline in cannabis use in adolescents and state legalization, the fear-mongering of prohibitionists that hordes of kids are going to start smoking weed has been proven wrong.
The results of this study suggest another intriguing reality—as the taboo of something is removed, it can become less appealing or less ripe for abuse. Since kids can get real infor [...]
TheCannabisVegan News: Henry Ford's 1941 Hemp, 2016 Electric Cannabis car & Vegan Hemp Burgers [...]
Bruce Linton, CEO of Canopy Growth (TSXV: CGC) (OTC:TWMJF), the parent company of Tweed and Bedrocan Cannabis, gave a TEDx talk in Kanata, Ontario on March 31st. The theme of the event was “breaking barriers”, but Linton actually praised them, ... [...]
Subscribe! Join our mailing list to receive weekly summaries of the latest cannabis news. SUBSCRIBE! You have Successfully Subscribed! Our Sponsor. Latest Articles. Cannabis Science and Policy Summit emphasizes harm reduction over commerce. [...]
... condition that require s frequent trips to the washroom. When I administer orally the frequency is drastically reduces. Subscribe! Join our mailing list to receive weekly summaries of the latest cannabis news. SUBSCRIBE! You have Successfully ... [...]
Pineapple Express (OTC: PNPL) was suspended by the SEC this morning. The company, which is a member of the 420 Investor Cannabis Stock Index (as of 3/31/16), is a recent reverse merger involving the former principals of Medbox, now known as Notis ... [...]
Chris Male of Anslinger Capital shared something today with our almost 4000 member LinkedIn group, Cannabis Investors & Entrepreneurs, that was just too good to be true. I dismissed it incorrectly as fake news, but indeed it is true: Walgreens (NASDAQ: ... [...]